 |
Selegiline HCl |
|---|---|
| Trade Name | Eldepryl |
| Orphan Indication | As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism |
| USA Market Approval | USA |
| USA Designation Date | 1984-11-07 00:00:00 |
| Sponsor | Somerset Pharmaceuticals, Inc.;400 Morris Ave., Suite 7s;Denville, New Jersey, 07834 |
